Literature DB >> 29016759

Access to magnetic resonance imaging of patients with magnetic resonance-conditional pacemaker and implantable cardioverter-defibrillator systems: results from the Really ProMRI study.

Eduardo Celentano1, Vincenzo Caccavo2, Matteo Santamaria3, Claudia Baiocchi4, Donato Melissano5, Ennio Pisanò6, Paolo Gallo7, Antonio Polcino8, Giuseppe Arena9, Santina Patanè10, Gaetano Senatore11, Giovanni Licciardello12, Luigi Padeletti13, Antonello Vado14, Davide Giorgi15, Domenico Pecora16, Prospero Stella17, Matteo Anaclerio18, Ciro Guastaferro19, Tiziana Giovannini20, Daniele Giacopelli21, Alessio Gargaro21, Giampiero Maglia22.   

Abstract

Aims: The Really ProMRI study evaluates magnetic resonance imaging (MRI) access for patients with cardiac implantable electronic devices (CIEDs) as well as the performance of magnetic resonance (MR)-conditional leads when undergoing MRI. Methods and results: Patients either with an MR-conditional pacemaker or implantable defibrillator (ICD) system or with at least a component (device or one or more leads) from an MR-conditional system, were asked to fill in a questionnaire when they were referred to a MR scan. The rate of prescription, denial, or execution of MR examinations was evaluated in a 1-year follow-up visit. In total, 555 patients [median age (interquartile range) 72.2 (62.2-78.6); 72% male] were enrolled, 49% (270) with a pacemaker, 51% (285) with an ICD system. Five-hundred and ten patients completed the follow-up period. A total of 37 MRI referrals were reported in 35 patients, with a consequent event rate of 7.0/100 patient-years (CI, 4.9-9.7). Fourteen were denied, while 23 [66%; (CI, 48-81%)] were performed. The number of patients with MR referrals was not statistically different between pacemaker and ICD groups (21 vs. 14; P = 0.178). The rate of scans performed was higher in the pacemaker subjects (19/23 vs. 4/14, P = 0.003), while it was similar between patients with or without a complete MR-conditional system (19/30 vs. 4/7, P = 0.606).
Conclusion: In this study, we reported a 7.0/100 patient-year's event rate of MR prescriptions in CIED patients. Many examinations were denied, despite MR-conditional systems, especially in ICD patients. Regulatory and cultural changes are needed to allow wider access to MR imaging in CIED patients with MR-conditional systems.

Entities:  

Mesh:

Year:  2018        PMID: 29016759     DOI: 10.1093/europace/eux118

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  MRI of Patients with Cardiac Implantable Electronic Devices.

Authors:  Jessica A Martinez; Daniel B Ennis
Journal:  Curr Cardiovasc Imaging Rep       Date:  2019-05-27

2.  Provision of MR imaging for patients with cardiac implantable electronic devices (CIEDs): a single-center experience and national survey.

Authors:  Aoife S Murray; Paddy J Gilligan; James M Bisset; Chris Nolan; Joseph M Galvin; John G Murray
Journal:  Ir J Med Sci       Date:  2018-10-27       Impact factor: 1.568

3.  MRI for patients with cardiac implantable electronic devices: simplifying complexity with a 'one-stop' service model.

Authors:  Anish N Bhuva; Patricia Feuchter; Angela Hawkins; Lizette Cash; Redha Boubertakh; Jane Evanson; Richard Schilling; Martin Lowe; James C Moon; Charlotte H Manisty
Journal:  BMJ Qual Saf       Date:  2019-02-13       Impact factor: 7.035

4.  Need for MRI scans in a real-world CIED population over long-term follow-up: Data from a large single-centre experience.

Authors:  Giosuè Mascioli; Elena Lucca; Federica Michelotti; Luca Tarantino; Fabrizio Giofré; Ilaria Finamora
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

5.  Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices.

Authors:  Anish N Bhuva; Russell Moralee; Tamara Brunker; Karen Lascelles; Lizette Cash; Kush P Patel; Martin Lowe; Neha Sekhri; Francisco Alpendurada; Dudley J Pennell; Richard Schilling; Pier D Lambiase; Anthony Chow; James C Moon; Harold Litt; A John Baksi; Charlotte H Manisty
Journal:  Eur Heart J       Date:  2022-07-07       Impact factor: 35.855

6.  Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.

Authors:  Wolfgang Rudolf Bauer; Dennis H Lau; Christian Wollmann; Andrew McGavigan; Jacques Mansourati; Theresa Reiter; Simone Frömer; Mark E Ladd; Harald H Quick
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.